Related Experiment Video

Updated: May 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Therapeutic strategies for head and neck cancer based on p53 status

Ichiro Ota1, Noritomo Okamoto, Katsunari Yane

  • 1Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Kashihara, Nara 634-8522;

Experimental and Therapeutic Medicine
|September 13, 2012
PubMed

Insights

p53 pathway alterations are common in head and neck cancers (HNSCC). Understanding p53 status is crucial for effective HNSCC treatment, influencing tumor aggressiveness and therapy resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Head and neck squamous cell carcinomas (HNSCC) are globally prevalent and pose significant treatment challenges.
  • Inactivation of the p53 signaling pathway is frequent in HNSCC and other cancers.
  • Loss of p53 function correlates with increased tumor aggressiveness and resistance to chemotherapy and radiotherapy.

Purpose of the Study:

  • To review the role of p53 signaling pathways in HNSCC.
  • To highlight the importance of p53 status in therapeutic decision-making for HNSCC patients.

Main Methods:

  • This review synthesizes current knowledge on p53 signaling pathways.
  • It examines how cellular stresses, including cancer therapies, activate these pathways.
  • The role of p53 status in HNSCC progression and treatment response is discussed.

Main Results:

  • Alterations in the p53 pathway are a hallmark of HNSCC.
  • Both deleted and mutated p53 expression impact tumor behavior and treatment outcomes.
  • p53 status influences chemoresistance and radioresistance in HNSCC.

Conclusions:

  • Assessing the p53 status in HNSCC is a critical factor for treatment planning.
  • Manipulating the p53 pathway or considering its status can optimize therapeutic strategies.
  • Recognizing p53 status aids in selecting effective treatment approaches for HNSCC.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...